• Site Search
  • Lawyer Search

Life Sciences

  • Print PDF
  • Subscribe to RSS
  • MoFolder
Jury Buys Plaintiff’s Argument That Drug Manufacturer Should Have Distributed Dear Doctor Letter Sooner, Without Prior FDA Approval
James Huston, Ellen Adler, and Joanna Simon
5/15/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Bowman v. Monsanto: Crisis Averted on IP Protection for Self-Replicating Technologies
Matthew Chivvis, Matthew Kreeger, and Michael Ward
5/14/2013
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Mind the gap: Sixth Circuit finds room for suit against generics after Mensing
International Law Office
James Huston, Erin Bosman, Julie Park, and Jeffrey David
4/9/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
A Narrow Exception To The Mensing Preemption Defense
Law360
James Huston, Erin Bosman, Julie Park, and Jeffrey David
4/4/2013
Appellate + Supreme Court, Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
Driving on both sides of the road: Supreme Court hears Bartlett oral argument
International Law Office
James Huston, Erin Bosman, Julie Park, and Joanna Simon
4/2/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
Breaking Down The Bartlett Oral Argument
Life Sciences Law360
James Huston, Erin Bosman, Julie Park, and Joanna Simon
4/1/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
Howard v. Zimmer: Negligence Per Se Based on Violations of the FDCA—Blurring the Line Between Parallel Claims and Preemption
James Huston, Erin Bosman, and Joanna Simon
3/27/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Driving on Both Sides of the Road: Supreme Court Hears Bartlett Oral Argument
James Huston, Erin Bosman, Julie Park, and Joanna Simon
3/20/2013
Appellate + Supreme Court, Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Mind the Gap: Sixth Circuit Finds Room for Suit Against Generic Manufacturers After Mensing
James Huston, Erin Bosman, Julie Park, and Jeffrey David
3/14/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
MoFo Biometer
Volume 2, Issue 1
Stephen Thau and Anelia Delcheva
2/25/2013
Emerging Companies + Venture Capital, Life Sciences
Newsletter
America Invents Act: USPTO Publishes Final Examination Guidelines for the First-Inventor-to-File Provisions
Randy Omid and Otis Littlefield
2/19/2013
Intellectual Property Litigation, Interferences, IP Due Diligence, Life Sciences, Patent Counseling + Prosecution, Patent Litigation, Patent Reexaminations
Client Alert
Australian Federal Court Upholds Myriad’s Gene Patent
James Mullen and Mary Prendergast
2/15/2013
Intellectual Property, Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution
Client Alert
Weeks defies years of jurisprudence, allowing innovator liability for generic drugs
International Law Office
James Huston, Erin Bosman, and Julie Park
2/12/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Wyeth v. Weeks: Implications for Pharma Manufacturers
Law360
James Huston, Erin Bosman, and Julie Park
2/6/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Beineke v. Kappos - Are Discovered Plants Patentable?
Matthew Chivvis, Rachel Krevans, and Michael Ward
1/28/2013
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Generic Drug Liability Ruling Raises Concerns
Business Insurance
Erin Bosman and James Huston
1/28/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Anticipating First-to-File: What to do to Prepare for the United States Patent System’s Change to First-to-File
Otis Littlefield
1/23/2013
Intellectual Property Litigation, Interferences, IP Due Diligence, Life Sciences, Patent Counseling + Prosecution, Patent Litigation, Patent Reexaminations
Client Alert
The Broad Reach Of New 'Failure-To-Warn-FDA' Claims
Law360
Erin Bosman, Joanna Simon, and Julie Park
1/23/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Weeks Defies Years of Jurisprudence, Allowing Innovator Liability for Generic Drugs
James Huston, Erin Bosman, and Julie Park
1/17/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
China Life Sciences Newsletter
中国生命科学通讯
Gabriel Bloch, Peng Chen, Thomas Chou, Gordon Milner, and Kun Wang
1/16/2013
China, Corporate, Intellectual Property, Licensing + Technology Transactions, Life Sciences
Newsletter
Stengel Tangles MDA Preemption:
Ninth Circuit Decision Creates Split on Buckman Preemption of Post-Market Reporting Requirements
Erin Bosman, Joanna Simon, and Julie Park
1/14/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
MoFo BioMeter
Stephen Thau, Anelia Delcheva, Van Ellis, Gabriel Meister, Julian Thurston, and Mark Wicker
12/12/2012
Emerging Companies + Venture Capital, Life Sciences
Newsletter
Second Circuit Delivers Blow to Off-Label Promotion Prosecutions in U.S. v. Caronia
Adam Hoffinger, Robert Salerno, and Demme Doufekias
12/5/2012
Health Care Fraud – Investigations + Litigation, Life Sciences, Pharmaceutical + Medical Device, White-Collar Defense
Client Alert
Supreme Court to Hear Design Defect Preemption Case
James Huston, Erin Bosman, and Julie Park
12/3/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Myriad Finally Gets Its Day in (the Supreme) Court
James Mullen and Mary Prendergast
11/30/2012
Appellate + Supreme Court, Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Sound the Alarm?—The Supreme Court’s Renewed Interest in Life Sciences Patents Could Create Additional Hurdles Across the Field
Matthew Chivvis, Rachel Krevans, and Michael Ward
11/16/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
District Court Decision Opens Door to Additional Patent Term Adjustment
Janet Xiao
11/14/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Physician Payment Sunshine Act: Challenge for Companies, Tool for Enforcers
Adam Hoffinger, Robert Salerno, and Demme Doufekias
10/19/2012
Health Care Fraud – Investigations + Litigation, Life Sciences, Pharmaceutical + Medical Device, White-Collar Defense
Client Alert
Patent Exhaustion and Self-Replicating Technologies
The Solicitor General Asks the Supreme Court to Decline Review in Bowman v. Monsanto
Matthew Chivvis, Michael Ward, and Rachel Krevans
9/5/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Judges Don't Budge in Myriad:
Federal Circuit Again Finds Isolated Gene Sequences are Patent-Eligible Subject Matter
James Mullen and Mary Prendergast
8/16/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Fast and Furious (Toward Patents): USPTO Issues Final Post-Grant Rules
Mehran Arjomand and Stephen Jones
8/15/2012
Intellectual Property Litigation, Interferences, IP Due Diligence, Life Sciences, Patent Counseling + Prosecution, Patent Litigation, Patent Reexaminations
Client Alert
USPTO Issues Interim Guidance for Subject Matter Eligibility in the Wake of Prometheus
Janet Xiao and Matthew Show
7/10/2012
Intellectual Property Litigation, Life Sciences, Patent Litigation
Client Alert
The Patent Office Knows the Way to San Jose (and Denver and Dallas)
Brian Ho and Michael Ward
7/3/2012
Life Sciences, Patent Counseling + Prosecution
Client Alert
Intellectual Property Quarterly Newsletter
Summer 2012
Eric Acker, Brian Donahue, Cary Miller, Gladys Monroy, Terri Shieh-Newton, and Matthew Show
6/28/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Newsletter
Pathway for Follow-on Biologics Survives the Supreme Court
Amy Mills and Cary Miller
6/28/2012
Life Sciences
Client Alert
FDA Bone Drug Study Offers New Pathway For Plaintiffs
Product Liability Law360
James Huston
5/10/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Implications — And Complications — Of Undoing Mensing
Law360
James Huston, Erin Bosman, and Julie Park
5/7/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Evaluating the Impact of Mayo for Diagnostics Companies
Matthew Kreeger and Otis Littlefield
Available Until July 23, 2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution
Multimedia
China Life Sciences Newsletter
中国生命科学通讯
David Chang, Peng Chen, Thomas Chou, Charles Comey, Patrick Fischer, Michael Jacobs, Paul McKenzie, Gordon Milner, Gregory Tan, Julian Thurston, Kun Wang, Janet Xiao, and Jie Zhou
4/24/2012
Life Sciences, Life Sciences | China, Life Sciences | Europe, Life Sciences | Japan
Newsletter
Bill Seeks to Undo Mensing Decision and Allow Patients to Sue Generic Drug Makers for Failure to Warn
James Huston, Erin Bosman, and Julie Park
4/19/2012
Consumer Litigation, Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Plaintiffs Sue Abbott, McKesson over Drug Label
San Francisco Daily Journal
Erin Bosman
4/16/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Patent Exhaustion and Self-Replicating Technologies: What Might the Supreme Court Say?
Matthew Chivvis, Rachel Krevans, and Michael Ward
4/10/2012
Life Sciences, Patent Counseling + Prosecution
Client Alert
Pharma Group Pans FDA Guidance On Off-Label Info Sharing
Product Liability Law360
4/3/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
FDA Could Make Generics Liable Amid Push To Undo Mensing
Product Liability Law360
James Huston
3/28/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
The JOBS Act
David Lynn and Anna Pinedo
3/26/2012
Capital Markets, Corporate, Debt Offerings + 144A Offerings, Emerging Companies + Venture Capital, Life Sciences, Private Placements + PIPEs, Public Companies Counseling + Compliance
Client Alert
Uncertainty Prevails:
Myriad Back to the Federal Circuit
James Mullen and Mary Prendergast
3/26/2012
Appellate + Supreme Court, Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Marine Polymer v. HemCon:
Intervening Rights Result From a Reexamination Only Where Claims are Added or Changes are Made to Claim Language
Peng Chen and Desmond O'Sullivan
3/21/2012
Intellectual Property Litigation, Life Sciences, Patent Litigation
Client Alert
Mayo v. Prometheus: The Supreme Court Finds Certain Medical Diagnostic Claims Are Not Patent-Eligible
Matthew Chivvis, Kate McElhone, and James Mullen
3/20/2012
Appellate + Supreme Court, Life Sciences, Patent Litigation
Client Alert
Intellectual Property Quarterly Newsletter
Eric Acker, Gabrielle Holburt, Brian Kramer, Scott Moore, and Christopher Wiener
Winter 2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Newsletter
FDA Issues Draft Guidance Documents for Biosimilars
Cary Miller, Amy Mills, and Kun Wang
2/13/2012
Intellectual Property, Life Sciences, Life Sciences | China, Life Sciences | Japan, Patent Counseling + Prosecution, Pharmaceutical + Medical Device, Product Liability
Client Alert
View All
This is MoFo.
© 1996-2013 Morrison & Foerster LLP. All rights reserved.
[ A- | A+ ]
Loading...
Loading...